Disease and Therapy Review Rheumatoid Arthritis

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Teijin Pharma Limited SWOT Analysis, Strategy, Revenues and Profits

Teijin Pharma Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • June 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States, Spain, South Korea, Japan, China

Colon Cancer Treatment Drugs Markets in China

Colon Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • by Asia Market Information & Development Company
  • June 2014
  • 173 pages

China's demand for Colon Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, ...

Industries: Pathology | Countries: China

Cervical Cancer Treatment Drugs Markets in China

Cervical Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • by Asia Market Information & Development Company
  • June 2014
  • 193 pages

China's demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, ...

Industries: Pathology | Countries: China

Cancer Treatment Drugs Markets in China

Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • by Asia Market Information & Development Company
  • May 2014
  • 236 pages

China's demand for Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry ...

Industries: Pathology | Countries: China

Home Testing Products Markets in China

Home Testing Products Markets in China

  • $ 4 000
  • Industry report
  • by Asia Market Information & Development Company
  • May 2014
  • 215 pages

China's demand for Home Testing Products has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry ...

Industries: Pathology, Health Insurance | Countries: China

MediPoint: Companion Diagnostic Tests in Oncology - APAC Analysis and Market Forecasts

MediPoint: Companion Diagnostic Tests in Oncology - APAC Analysis and Market Forecasts

  • $ 4 450
  • Industry report
  • by Global Data
  • May 2014
  • 446 pages

MediPoint: Companion Diagnostic Tests in Oncology - APAC Analysis and Market Forecasts Summary A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence ...

Industries: Pathology | Countries: China, Japan, India

Eli Lilly and Company (Symbol:LLY) SWOT Analysis, Strategy, Revenues and Profits

Eli Lilly and Company (Symbol:LLY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • May 2014
  • 67 pages

Eli Lilly and Company (Lilly) is a pharmaceutical company, which is principally engaged in the design, development, manufacture, and selling of pharmaceutical products by utilizing up-to-date technological tools. It also conducts research to discover products to treat disease in animals. The company ...

Industries: Pathology | Countries: United States, China

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

  • $ 6 495
  • Industry report
  • by Global Data
  • May 2014
  • 592 pages

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts Summary A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression o ...

Industries: Pathology | Countries: World, France, China, Italy, Japan, Brazil, Germany, India, Spain, United Kingdom, United States, Europe

Eczema - Pipeline Review, H1 2014

Eczema - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • April 2014
  • 46 pages

Eczema - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Eczema - Pipeline Review, H1 2014', provides an overview of the Eczema's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Eczema, complete with comparative analysis at various ...

Industries: Pathology | Countries: World, Norway, China, United States

Shanghai Institute of Materia Medica Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Shanghai Institute of Materia Medica Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • April 2014
  • 17 pages

Summary Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is an educational research Institute. It aims to strengthen research and development of Traditional Chinese Medicine (TCM). The institute provides comprehensive solutions in the areas of drug discovery and drug development. ...

Industries: Pathology | Countries: China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.